comparemela.com

Alan Susan Hudson News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Bluerock Therapeutics Receives FDA Regenerative Medicine Advanced Therapy Designation For Parkinson S Disease Cell Therapy Candidate Bemdaneprocel

.Regenerative

Nova scotiaUnited kingdomUnited statesAndres lozanoJeff lockwoodSeth ettenbergAlan susan hudsonHarini sarvaClaire henchcliffeViviane tabarAlfonso fasanoCarolyn nagleChristian rommelKrembil brain instituteBayer pharmaceuticals division weBayer investor relations team

BlueRock s Phase I study with bemdaneprocel in patients with Parkinson s disease meets primary endpoint

Investigational cellular therapy, bemdaneprocel (BRT-DA01), was well tolerated with no major safety issues in all 12 participants in low dose and high dose.

United statesUnited kingdomHarini sarvaAlfonso fasanoChristian rommelAlan susan hudsonClaire henchcliffeAhmed enayetallahViviane tabarAndres lozanoUniversity health networkUniversity of toronto uoCancer centerInternational congressDepartment of neurosurgery at memorial sloan ketteringMovement disorders

vimarsana © 2020. All Rights Reserved.